While the spotlight has traditionally focused on a group of well-known ‘legacy’ PFAS such as perfluorooctanesulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and perfluorohexane sulfonate (PFHS), which are already regulated under the 2001 Stockholm Convention on Persistent Organic Pollutants, the chemical landscape continues to evolve. New generations of PFAS have emerged in the market, often touted as safer alternatives. However, recent cutting-edge research underscores that these newer compounds may not be as benign as initially hoped. In a groundbreaking study published in the journal Frontiers in Aging, scientists have unveiled the concerning biological effects of two such compounds, perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), which appear to accelerate the aging process at a cellular level.

Dr. Xiangwei Li, a professor at Shanghai Jiao Tong University School of Medicine and the principal investigator of the study, emphasized the significance of these findings. “Our research demonstrates that specific forever chemicals, namely PFNA and PFOSA, expedite biological aging, especially in men aged between 50 and 64,” Li stated. He further cautioned that the assumption of newer PFAS as low-risk replacements is misguided, suggesting a pressing need to reevaluate regulatory frameworks to encompass these evolving contaminants. The study offers a lucid perspective on how these substances can insidiously disrupt biological systems, leading to accelerated aging and potential health complications.

The research team leveraged a robust data source—the US National Health and Nutrition Examination Survey (NHANES)—which provides a comprehensive, nationally representative cohort of older adults enrolled around the turn of the century. Blood samples from 326 participants were analyzed for concentrations of 11 different PFAS compounds. Notably, the team employed DNA methylome profiling, a sophisticated epigenetic technique that quantifies DNA methylation patterns controlling gene expression. By integrating these epigenetic markers into state-of-the-art algorithms known as ‘epigenetic clocks,’ they estimated the biological age of each individual, revealing a nuanced relationship between PFAS exposure and the pace of biological aging.

Intriguingly, the researchers discovered that PFNA and PFOSA were present in the blood of an overwhelming 95% of participants, signaling their pervasive nature. More critically, elevated levels of these chemicals correlated strongly with accelerated epigenetic aging in middle-aged men but not in women. This sexual dimorphism in response raises compelling questions about underlying mechanisms, possibly related to differences in metabolism, hormone regulation, or lifestyle factors that may amplify vulnerability. PFNA and PFOSA, synthesized originally between the 1950s and 1960s, find extensive application in consumer and industrial products due to their exceptional durability against heat, corrosion, and various forms of contamination.

Other PFAS compounds, including two acetic acid derivatives—2-(N-ethyl-perfluorooctane sulfonamido) acetic acid (EPAH) and 2-(N-methyl-perfluorooctane sulfonamido) acetic acid (MPAH)—as well as PFOS, PFOA, and PFHS, were also highly prevalent, detected in at least 85% of the subjects. However, the study interestingly found no significant association between these compounds and biological age, nor any gender or age-related variations in their concentrations. These findings imply compound-specific differences in biological impact, underscoring the complexity of PFAS chemistry and toxicology.

The team concluded that the effects of PFAS on epigenetic aging are not uniform across all compounds, pointing to the inadequacy of current regulations that primarily target legacy PFAS. Most notably, they argued for urgent regulatory attention to include compounds like PFNA and PFOSA, which remain largely overlooked in policy discussions despite emerging evidence of their harmful effects. As the landscape of chemical manufacturing continues to evolve, the need for dynamic, evidence-based oversight mechanisms that consider newer contaminants becomes paramount.

A particularly compelling aspect of the study is the age and gender-specific vulnerability highlighted. Middle-aged men, it seems, represent a uniquely sensitive demographic in the context of PFAS-induced aging. Dr. Ya-Qian Xu, the first author of the study, elucidated this pattern by pointing to midlife as a critical biological window. During this period, physiological systems become increasingly susceptible to various stressors—including chemical exposures—which may exacerbate aging processes. Dr. Li supplemented this view, hypothesizing that lifestyle factors more prevalent in men, such as smoking, might synergize with PFAS effects to accelerate biological wear and tear.

Globally, the regulatory environment is beginning to address PFAS concerns more proactively. France has already enacted a nationwide ban on PFAS usage in clothing and cosmetics, while the European Union considers imposing similar restrictions on select applications. These proactive measures reflect a growing recognition of the urgent need to mitigate exposure risks through legislative means. Experts advocate for further initiatives, urging manufacturers, policymakers, and consumers alike to prioritize reducing PFAS dissemination via industrial processes and product formulations.

In the interim, individuals can adopt practical strategies to reduce their PFAS exposure. The study’s authors recommend minimizing consumption of packaged foods, which often involve PFAS-laden materials, and avoiding practices like microwaving food in fast-food containers, which can increase chemical leaching. These measures, albeit small, contribute to limiting cumulative toxicity over time. Looking forward, the research team aims to expand investigations into how PFAS interact with other prevalent environmental pollutants to better elucidate the complex, cumulative health implications of these chemical mixtures.

This research not only deepens the understanding of PFAS toxicity but also exemplifies the power of epigenetics as a tool to measure and interpret the biological consequences of environmental exposures. By linking chemical pollutants with accelerated aging signatures, the study provides compelling evidence that could reshape public health policies and environmental standards. The pressing challenge remains: how to balance industrial and consumer benefits of these durable chemicals against their insidious and far-reaching biological costs. As this body of evidence grows, it becomes increasingly clear that the covert legacy of forever chemicals demands sustained scientific and regulatory vigilance.

Subject of Research: People
Article Title: Not specified in the provided content
News Publication Date: Not specified, but article publication date: 26-Feb-2026
Web References: https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1722675/full
References: Not provided
Image Credits: Not provided
Keywords: PFAS, perfluorononanoic acid, PFNA, perfluorooctanesulfonamide, PFOSA, biological aging, epigenetic clock, DNA methylome, environmental toxicology, gender differences, middle-aged men, persistent organic pollutants

Exposure to PFAS poses significant challenges, especially because they enter the human body through various pathways including contaminated food, drinking water, and air. While these compounds are not acutely toxic, chronic exposure is nearly unavoidable in modern societies. This sustained presence and bioaccumulation raise serious concerns about long-term health outcomes, particularly in vulnerable subpopulations such as pregnant women, young children, and individuals with chronic illnesses. Such groups may experience heightened risks due to the subtle but persistent effects of these chemicals.

Scientific investigations have uncovered associations between PFAS exposure and several detrimental health conditions, including metabolic disorders like obesity, disruptions in hormonal balance, and increased cancer risk. Beyond these effects, PFAS are now recognized as modulators of the immune system, a revelation that carries significant implications for public health. Recent epidemiological data highlight how PFAS compromise immune responses, notably by dampening antibody production following vaccination against infectious diseases, with SARS-CoV-2 being a prominent example.

Understanding the intricacies of the immune system’s response to PFAS exposure is critical, especially given the ongoing global challenges posed by COVID-19. Immunity against SARS-CoV-2 involves both humoral immunity mediated by antibodies and cellular immunity driven by T cells and other immune components. While antibody levels have traditionally been used as a marker of vaccine effectiveness, they do not tell the entire story. The cellular arm of the immune response is equally vital for protection against severe infections but has been less studied in the context of PFAS exposure.

Addressing this knowledge gap, a collaborative research team led by Professor Ana Zenclussen from the Helmholtz Centre for Environmental Research (UFZ) conducted an in-depth experimental study focused on how PFAS influence cellular immune responses in individuals vaccinated against SARS-CoV-2. By isolating peripheral blood mononuclear cells (PBMCs) from vaccinated individuals with prior COVID-19 infection, the researchers were able to meticulously examine immune cell behavior when exposed to PFAS in laboratory conditions. This approach allowed for controlled analyses of direct effects, bypassing the complexity of whole-body interactions that often obscure mechanistic insights.

Central to the study’s design was the use of a PFAS mixture carefully calibrated to mimic real-world exposure levels observed across European populations. This mixture was developed in collaboration with Norwegian partners from the Institute of Public Health in Oslo and was derived from extensive cohort data to ensure ecological validity. To explore dose-dependent effects, the immune cells were also subjected to PFAS concentrations up to a thousand times higher, simulating exposure scenarios relevant to workers in PFAS production facilities.

Following a 24-hour incubation with the PFAS mixture, the PBMCs were then stimulated with SARS-CoV-2 spike proteins to evaluate their immune responsiveness. Cutting-edge spectral flow cytometry was employed to dissect the immune cell repertoire with high resolution, enabling quantification and identification of multiple immune subsets within a single assay. This technology also facilitated the measurement of cytokines and chemokines—immune signaling molecules that dictate cell communication and functional responses.

The results painted a nuanced and concerning picture. At elevated PFAS concentrations, two distinct types of immune cells displayed an exaggerated inflammatory response when re-exposed to SARS-CoV-2 antigens. This phenomenon, characterized by increased secretion of inflammatory mediators, suggests a dysregulated immune activation that may have harmful consequences if replicated in vivo. Intriguingly, this hyperinflammatory trend was markedly more pronounced in the samples derived from male participants, hinting at potential sex-specific vulnerabilities.

Conversely, female participants’ immune cells exhibited a different pattern. Higher PFAS exposure correlated with a reduction in B cell populations, the specialized lymphocytes responsible for producing antibodies and sustaining long-term immunity. Such depletion could undermine humoral immune memory and impair vaccine efficacy, raising important questions about sex-based differences in immune modulation by environmental contaminants.

Moreover, the production of key soluble immune mediators involved in recruiting other immune cells to the site of infection and in tissue repair processes was adversely affected across both sexes. These functional impairments further underscore the potential for PFAS to not only skew immune responses but also impede the resolution phase of inflammation, which is critical for restoring tissue homeostasis after viral challenges.

Collectively, these findings underscore the complexity of PFAS-induced immunomodulation and highlight the potential public health ramifications. Individuals experiencing high PFAS burdens—whether occupationally or environmentally—might face increased risks of suboptimal vaccine responses and more severe disease progression if infected with SARS-CoV-2 or similar pathogens. Tailoring vaccination strategies to account for such environmental exposures could become an essential component of personalized medicine and epidemiological planning.

Professor Ana Zenclussen emphasized the significance of these discoveries, noting that this research fills a crucial gap in understanding how chronic environmental pollutants alter cellular immunity. The sex-differentiated effects warrant further investigation to inform risk assessments and public health interventions that consider biological variability.

Dr. Oddvar Myhre of the Norwegian Institute of Public Health highlighted the methodological strengths of the study, particularly the use of human-relevant PFAS mixtures reflective of actual exposure scenarios. This approach moves beyond single-compound toxicology, embracing the complex interactions found in real-world PFAS contamination and its health consequences.

As PFAS contamination continues to be a pressing environmental and health issue globally, studies like this provide critical mechanistic insights that bridge laboratory findings with epidemiological trends. The integration of advanced immunological techniques, realistic exposure models, and interdisciplinary collaboration marks a new frontier in assessing how “forever chemicals” impact human health at the immune system level.

Future research directions should include long-term cohort studies tracking PFAS exposure alongside vaccine responsiveness and infection outcomes, stratified by sex and other demographic factors. Intervention strategies to reduce PFAS exposure and mitigate its immunotoxic effects should also be prioritized to protect vulnerable populations and enhance global health resilience.

Subject of Research: Cells
Article Title: Evaluating PFAS-Induced modulation of peripheral blood mononuclear cells (PBMCs) immune response to SARS-CoV-2 spike in COVID-19 Vaccinees
News Publication Date: 26-Mar-2025
Web References: 10.1016/j.envint.2025.109409

Keywords

PFAS, immune modulation, SARS-CoV-2, COVID-19 vaccination, cellular immunity, peripheral blood mononuclear cells, spectral flow cytometry, sex differences, environmental contaminants, chronic exposure, immunotoxicity, antibody response